acetylgalactosamine has been researched along with Liver Cirrhosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, JS; Chan, A; Charisse, K; Jadhav, V; Maier, MA; Manoharan, M; Nair, JK; Nguyen, T; Qian, K; Racie, T; Rajeev, KG; Sehgal, A; Shulga-Morskaya, S; van Berkel, TJC; Willoughby, JLS; Yucius, K; Zimmermann, TS | 1 |
| Hayes, P; Mooney, P; Smith, K | 1 |
2 other study(ies) available for acetylgalactosamine and Liver Cirrhosis
| Article | Year |
|---|---|
Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
Topics: Acetylgalactosamine; Animals; Asialoglycoprotein Receptor; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; Gene Expression Regulation; Gene Silencing; Hepatocytes; Humans; Liver Cirrhosis; Mice; Mice, Knockout; Protein Subunits; RNA Interference; RNA, Small Interfering | 2018 |
The putative use of alpha-1-acid glycoprotein as a non-invasive marker of fibrosis.
Topics: Acetylgalactosamine; Adult; Biomarkers; Chromatography, Ion Exchange; Concanavalin A; Enzyme-Linked Immunosorbent Assay; Fucose; Glycosylation; Humans; Liver Cirrhosis; Middle Aged; N-Acetylneuraminic Acid; Orosomucoid | 2006 |